Abbott, WARF Clash With Teva Over Zemplar

By Jesse Greenspan · November 24, 2008, 12:00 AM EST

Abbott Laboratories and the Wisconsin Alumni Research Foundation have initiated a patent lawsuit aimed at keeping Teva Pharmaceutical Industries Ltd. from marketing a generic version of the drug Zemplar, used to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Complaint

Recent Articles By Jesse

May 12, 2011
Executive Risk Must Cover Hospital Privacy Row: Judge
May 09, 2011
DOD Services Contracts Outpace Other Growth
April 28, 2011
Merck To Abide By Discharge Diet To End Enviro Suit
April 27, 2011
FOIA Request Filed As Avastin Safety Hearing Nears
April 15, 2011
Cypress Sued Over Unapproved Cold Medication
April 14, 2011
FDA Recalls Radiation Shield That Sheds Tungsten
April 01, 2011
BSC Poached Worker Suit To Move Forward In Calif.
March 17, 2011
Mont. Orders AG To Join Health Care Reform Challenge
March 15, 2011
Gilead, Roche Sue To Block Generic Tamiflu
March 14, 2011
Pa. Action Over Dead Health Care Plan Targets Pols